This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4k26
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | {{STRUCTURE_4k26| PDB=4k26 | SCENE= }} | |
| + | ===4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 -HSD1 inhibitors for the treatment of diabetes=== | ||
| + | {{ABSTRACT_PUBMED_23845218}} | ||
| - | + | ==Function== | |
| + | [[http://www.uniprot.org/uniprot/DHI1_MOUSE DHI1_MOUSE]] Catalyzes reversibly the conversion of cortisol to the inactive metabolite cortisone. | ||
| - | + | ==About this Structure== | |
| + | [[4k26]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4K26 OCA]. | ||
| - | + | ==Reference== | |
| + | <ref group="xtra">PMID:023845218</ref><references group="xtra"/><references/> | ||
| + | [[Category: 11-beta-hydroxysteroid dehydrogenase]] | ||
| + | [[Category: Engel, C K.]] | ||
| + | [[Category: Loenze, P.]] | ||
| + | [[Category: Schimanski-Breves, S.]] | ||
| + | [[Category: Vonderheyden, C.]] | ||
| + | [[Category: Alpha and beta protein]] | ||
| + | [[Category: Oxidoreductase]] | ||
| + | [[Category: Oxidoreductase-oxidoreductase inhibitor complex]] | ||
| + | [[Category: Short chain dehydrogenase]] | ||
Revision as of 06:27, 9 April 2014
Contents |
4,4-Dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 -HSD1 inhibitors for the treatment of diabetes
Template:ABSTRACT PUBMED 23845218
Function
[DHI1_MOUSE] Catalyzes reversibly the conversion of cortisol to the inactive metabolite cortisone.
About this Structure
4k26 is a 2 chain structure. Full crystallographic information is available from OCA.
Reference
- Bohme T, Engel CK, Farjot G, Gussregen S, Haack T, Tschank G, Ritter K. 1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11ss-HSD1 inhibitors for the treatment of diabetes. Bioorg Med Chem Lett. 2013 Aug 15;23(16):4685-91. doi:, 10.1016/j.bmcl.2013.05.102. Epub 2013 Jun 11. PMID:23845218 doi:http://dx.doi.org/10.1016/j.bmcl.2013.05.102
